Robuta

https://www.ncbi.nlm.nih.gov/Structure/pdb/3INU 3INU: Crystal structure of an unbound KZ52 neutralizing anti-Ebolavirus antibody KZ52 antibody fragment heavy chainKZ52 antibody fragment light chainGLYCEROLSULFATE ION crystal structure https://www.techtransfer.nih.gov/patent/e-004-2023-0-us-01 EBOLAVIRUS (SUDAN AND ZAIRE) ANTIBODIES FROM NON-HUMAN PRIMATES AND HUMAN VACCINEES | Technology... ebolavirussudanzaireantibodies https://species.wikimedia.org/wiki/Ebolavirus Ebolavirus - Wikispecies ebolaviruswikispecies https://mpra.ub.uni-muenchen.de/58948/ The Most Fatal 2014 Outbreak of Ebolavirus Disease in Western Africa Munich Personal RePEc Archive https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2020.570131/full Frontiers | Host Adaptation and Evolutionary Analysis of Zaire ebolavirus: Insights From Codon... Ebola virus (EBOV) has caused several outbreaks as the consequence of spillover events from zoonotic sources and has resulted in huge death tolls. In spite o... https://pubmed.ncbi.nlm.nih.gov/30107445/ Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors One year after a Zaire ebolavirus (EBOV) outbreak occurred in the Boende Health Zone of the Democratic Republic of the Congo during 2014, we sought to... https://www.businesswire.com/news/home/20230123005144/en/KBI-Biopharma-Announces-Subcontract-with-Mapp-Biopharmaceutical-on-Sudan-ebolavirus-Treatment KBI Biopharma Announces Subcontract with Mapp Biopharmaceutical on Sudan ebolavirus Treatment KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced it entered into a subcontract with Mapp Biopharmaceutical, Inc. (Mapp) for the contin... kbibiopharmaannouncessubcontract https://www.ncbi.nlm.nih.gov/Structure/pdb/6U54 6U54: Anti-Zaire ebolavirus Nucleoprotein Single Domain Antibody Zaire C (ZC) Complexed with Zaire... Anti-Zaire ebolavirus Nucleoprotein Single Domain Antibody Zaire C (ZC)Nucleoprotein single domain https://www.cordis.europa.eu/project/id/666085/results/it Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine | EbolaVac | Progetto |... Deliverables, publications, datasets, software, exploitable results of a https://www.cordis.europa.eu/project/id/666085/reporting/pl Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine | H2020 | CORDIS | Komisja... Latest report summary https://www.ncbi.nlm.nih.gov/Structure/pdb/4D9O 4D9O: Structure of ebolavirus protein VP24 from Reston Membrane-associated protein VP24 structureebolavirusproteinreston https://lod.nal.usda.gov/nalt/en/page/29579 NAL Agricultural Thesaurus: NALT: Tai Forest ebolavirus nalagriculturalthesaurustaiforest https://www.ncbi.nlm.nih.gov/gene/911825 VP40 matrix protein [Zaire ebolavirus] - Gene - NCBI matrixproteinzaireebolavirusgene https://asprtracie.hhs.gov/technical-resources/resource/5677/ebolavirus-diagnosis-made-simple-comparable-and-faster-than-molecular-detection-methods-preparing-for-the-future Ebolavirus Diagnosis Made Simple Comparable and Faster than Molecular Detection Methods Preparing... Search the ASPR TRACIE Resource Library and view tailored Topic Collections comprised of current healthcare system preparedness resources. made simple https://www.techtransfer.nih.gov/tech/tab-3164 Nucleic Acid Primers and Probes for Detecting Ebola Virus (species emZaire ebolavirus/em) |... https://www.ncbi.nlm.nih.gov/nuccore/OQ672967.1 Sudan ebolavirus isolate Ebolavirus/H.sapiens-wt/Uganda/2022/202200345 - Nucleotide - NCBI sudanebolavirusisolatehsapiens https://hsbiblio.uni-tuebingen.de/xmlui/handle/10900/148732 Zaire ebolavirus surveillance near the Bikoro region of the Democratic Republic of the Congo during... democratic republic congo https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0010205 First laboratory confirmation and sequencing of Zaire ebolavirus in Uganda following two... Author summary In the effort to control the on-going COVID-19 pandemic, countries instituted lock downs and closed international borders. But is this the best... https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1010518 Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region | PLOS... Author summary Recent breakthroughs in structure-based and computational-guided vaccine design have made methods available for transplanting epitopes from... https://adisinsight.springer.com/trials/700365938?error=cookies_not_supported&code=e96835f6-e40b-4ca1-a7b6-a8f92e56a101 Durability of Immunity Induced by the Ebolavirus Vaccine VSV-EBOV and As-sessment of a Booster Dose... This study is a multi-center, open label, randomized phase 3b trial to assess the durability of Immunity induced by the Ebolavirus Vaccine VSV-EBOV ( with or https://www.ncbi.nlm.nih.gov/nuccore/OQ673059.1 Sudan ebolavirus isolate Ebolavirus/H.sapiens-wt/Uganda/2022/202200275 - Nucleotide - NCBI sudanebolavirusisolatehsapiens https://pubmed.ncbi.nlm.nih.gov/40223186/ Dual roles of CXCR4 (C-X-C motif chemokine receptor 4) in promoting entry of ebolavirus and...